Advertisement

Bone Health in Patients with Type 2 Diabetes Treated by Roux-En-Y Gastric Bypass and the Role of Diabetes Remission

  • Lene Ring MadsenEmail author
  • Rasmus Espersen
  • Marie Juul Ornstrup
  • Niklas Rye Jørgensen
  • Bente Lomholt Langdahl
  • Bjørn Richelsen
Original Contributions
  • 28 Downloads

Abstract

Background

Roux-en-Y gastric bypass (RYGB) has been associated with negative effects on bone. Whether this association is affected by pre-surgical type 2 diabetes (T2D) and surgically induced diabetes remission is unknown.

Methods

In this cross-sectional, matched cohort study 6 years after RYGB, we investigated bone health in 96 individuals with body mass index (BMI) > 35 kg/m2 and T2D (stratified on current diabetes status) treated by RYGB 6 years earlier compared with 49 non-operated individuals with T2D matched with respect to sex, age, and current BMI. Main outcome measures were areal and volumetric bone mineral density (aBMD and vBMD), bone turnover, and odds ratio of osteoporosis/osteopenia.

Results

The RYGB group had lower hip (0.916 vs 1.010 g/cm2, p < 0.001), forearm (0.497 g/cm2 vs 0.554 g/cm2, p < 0.001) aBMD, (269.63 mg/cm3 vs 306.07 mg/cm3, p < 0.001) tibial, and radial (238.57 mg/cm3 vs 278.14 mg/cm3, p < 0.0001) vBMD than the control group. Relative to the control group, c-terminal cross-linked telopeptide, procollagen type I amino-terminal propeptide, and osteocalcin were 75%, 41%, and 72% higher in the RYGB group, respectively (all p < 0.001). Odds ratio for osteopenia/osteoporosis in operated individuals was 2.21 (95% CI 1.06; 4.79, p = 0.05). Overall, stratified analysis on current diabetes status did not alter these outcomes.

Conclusions

Individuals with T2D treated by RYGB, compared to individuals with T2D of similar age and body composition not treated by RYGB, have lower BMD, lower bone strength, and increased levels of several bone turnover markers. Bone health was not associated with current diabetes status in the RYGB group.

Keywords

Bariatric surgery Roux-en-Y gastric bypass Osteoporosis Type 2 diabetes Dual-energy X-ray absorptiometry Bone turnover Diabetes High-resolution peripheral quantitative computed tomography 

Notes

Acknowledgments

The authors would like to thank the staff at our outpatient clinic for help in recruiting participants.

Funding

LRM is affiliated to the Danish Diabetes Academy funded by the Novo Nordisk Foundation (NNF 12SA1016522). The study was funded by the Health Research Fund of Central Denmark Region (A294), the Novo Nordisk Foundation (NNF16OC0020870), the A.P. Møller Foundation (15–253), and the Danish Osteoporosis Society (grant number n/a).

Compliance with Ethical Standards

Conflict of Interest

LRM has received grant support from the Danish Diabetes Academy funded by the Novo Nordisk Foundation, the A.P. Møller Foundation, and the Health Research Fund of Central Denmark Region. RE has received grant support from the Danish Osteoporosis Society. MJO and NRJ have nothing to disclose. BL has received grant support from Amgen and Novo Nordisk and has received lecture fees from the advisory board of Amgen, UCB, Eli Lilly, and TEVA. BR has received grant support from the Novo Nordisk Foundation.

Ethical Approval

The study was approved by the ethical committee of Central Denmark Region (VEK 1-10-72-167-15) and registered at clinicaltrials.org (NCT02625649). The study was conducted according to the 1964 Declaration of Helsinki and its later amendments.

Informed Consent

Participation in this study was preceded by full explanation of the purpose and nature of all procedures used and written consent.

Supplementary material

11695_2019_3753_MOESM1_ESM.docx (30 kb)
ESM 1 (DOCX 30 kb)

References

  1. 1.
    Angrisani L, Santonicola A, Iovino P, Vitiello A, Zundel N, Buchwald H, Scopinaro N. Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obes Surg. 2017;27(9):2279–89Google Scholar
  2. 2.
    Chang SH, Stoll CR, Song J, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg. 2014;149(3):275–87.CrossRefGoogle Scholar
  3. 3.
    Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med. 2017;376(7):641–51.CrossRefGoogle Scholar
  4. 4.
    Yu EW. Bone metabolism after bariatric surgery. J Bone Miner Res. 2014;29(7):1507–18.Google Scholar
  5. 5.
    Pories WJ. Bariatric surgery: risks and rewards. J Clin Endocrinol Metab. 2008;93(11 Suppl 1):589–96.Google Scholar
  6. 6.
    Schafer AL, Weaver CM, Black DM, et al. Intestinal calcium absorption decreases dramatically after gastric bypass surgery despite optimization of vitamin D status. J Bone Miner Res. 2015;30(8):1377–85.CrossRefGoogle Scholar
  7. 7.
    Toh SY, Zarshenas N, Jorgensen J. Prevalence of nutrient deficiencies in bariatric patients. Nutrition. 2009;25(11–12):1150–6.CrossRefGoogle Scholar
  8. 8.
    Hage MP, El-Hajj Fuleihan G. Bone and mineral metabolism in patients undergoing Roux-en-Y gastric bypass. Osteoporos Int. 2014;25(2):423–39.CrossRefGoogle Scholar
  9. 9.
    Via MA, Mechanick JI. Nutritional and micronutrient care of bariatric surgery patients: current evidence update. Curr Obes Rep. 2017;6(3):286–96.CrossRefGoogle Scholar
  10. 10.
    Madsen LR, Espersen R, Rejnmark L, Richelsen B. Effect of calcium citrate vs calcium carbonate on elevated parathyroid hormone after Roux-en-Y gastric bypass. A double-blinded, randomized trial. Clin Endocrinol (Oxf). 2018;89(6):734–41Google Scholar
  11. 11.
    Raoof M, Naslund I, Rask E, et al. Effect of gastric bypass on bone mineral density, parathyroid hormone and vitamin D: 5 years follow-up. Obes Surg. 2016;26(5):1141–5.CrossRefGoogle Scholar
  12. 12.
    Vilarrasa N, San Jose P, Garcia I, et al. Evaluation of bone mineral density loss in morbidly obese women after gastric bypass: 3-year follow-up. Obes Surg. 2011;21(4):465–72.CrossRefGoogle Scholar
  13. 13.
    Billeter AT, Probst P, Fischer L, et al. Risk of malnutrition, trace metal, and vitamin deficiency post roux-en-y gastric bypass--a prospective study of 20 patients with BMI < 35 kg/m(2). Obes Surg. 2015;25(11):2125–34.CrossRefGoogle Scholar
  14. 14.
    Maghrabi AH, Wolski K, Abood B, et al. Two-year outcomes on bone density and fracture incidence in patients with T2DM randomized to bariatric surgery versus intensive medical therapy. Obesity (Silver Spring). 2015;23(12):2344–8.CrossRefGoogle Scholar
  15. 15.
    Yu EW, Wewalka M, Ding SA, et al. Effects of gastric bypass and gastric banding on bone remodeling in obese patients with type 2 diabetes. J Clin Endocrinol Metab. 2016;101(2):714–22.CrossRefGoogle Scholar
  16. 16.
    Hygum K, Starup-Linde J, Harslof T, et al. MECHANISMS IN ENDOCRINOLOGY: diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis. Eur J Endocrinol. 2017;176(3):R137–57.CrossRefGoogle Scholar
  17. 17.
    Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis. Osteoporos Int. 2007;18(4):427–44.CrossRefGoogle Scholar
  18. 18.
    Leslie WD, Rubin MR, Schwartz AV, et al. Type 2 diabetes and bone. J Bone Miner Res. 2012;27(11):2231–7.CrossRefGoogle Scholar
  19. 19.
    Stein EM, Silverberg SJ. Bone loss after bariatric surgery: causes, consequences, and management. Lancet Diabetes Endocrinol. 2014;2(2):165–74.CrossRefGoogle Scholar
  20. 20.
    Fuller H, Fuller R, Pereira RMR. High resolution peripheral quantitative computed tomography for the assessment of morphological and mechanical bone parameters. Rev Bras Reumatol. 2015;55:352–62.CrossRefGoogle Scholar
  21. 21.
    Stein EM, Carrelli A, Young P, et al. Bariatric surgery results in cortical bone loss. J Clin Endocrinol Metab. 2013;98(2):541–9.CrossRefGoogle Scholar
  22. 22.
    Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39(7 Suppl):30–3.CrossRefGoogle Scholar
  23. 23.
    Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, Inzucchi SE, McLaughlin S, Phillips GL 2nd, Robertson RP, Rubino F, Kahn R, Kirkman MS. How do we define cure of diabetes?. Diabetes Care. 2009;32(11):2133-5.Google Scholar
  24. 24.
    Dicker D, Yahalom R, Comaneshter DS, et al. Long-term outcomes of three types of bariatric surgery on obesity and type 2 diabetes control and remission. Obes Surg. 2016;26(8):1814-20.CrossRefGoogle Scholar
  25. 25.
    Looker AC, Melton 3rd LJ, Harris T, et al. Age, gender, and race/ethnic differences in total body and subregional bone density. Osteoporos Int. 2009;20(7):1141–9.CrossRefGoogle Scholar
  26. 26.
    Abrahamsen B, Gram J, Hansen TB, et al. Cross calibration of QDR-2000 and QDR-1000 dual-energy X-ray densitometers for bone mineral and soft-tissue measurements. Bone. 1995;16(3):385–90.CrossRefGoogle Scholar
  27. 27.
    Mosekilde L, Beck-Nielsen H, Sorensen OH, et al. Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women - results of the Danish osteoporosis prevention study. Maturitas. 2000;36(3):181–93.CrossRefGoogle Scholar
  28. 28.
    Ornstrup MJ, Harslof T, Kjaer TN, et al. Resveratrol increases bone mineral density and bone alkaline phosphatase in obese men: a randomized placebo-controlled trial. J Clin Endocrinol Metab. 2014;99(12):4720–9.CrossRefGoogle Scholar
  29. 29.
    Pauchard Y, Liphardt AM, Macdonald HM, et al. Quality control for bone quality parameters affected by subject motion in high-resolution peripheral quantitative computed tomography. Bone. 2012;50(6):1304–10.CrossRefGoogle Scholar
  30. 30.
    Yu EW, Bouxsein ML, Putman MS, et al. Two-year changes in bone density after Roux-en-Y gastric bypass surgery. J Clin Endocrinol Metab. 2015;100(4):1452–9.CrossRefGoogle Scholar
  31. 31.
    Stein EM, Silva BC, Boutroy S, et al. Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women. J Bone Miner Res. 2013;28(5):1029–40.CrossRefGoogle Scholar
  32. 32.
    Lalmohamed A, de Vries F, Bazelier MT, et al. Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study. BMJ. 2012;345:e5085.CrossRefGoogle Scholar
  33. 33.
    Rousseau C, Jean S, Gamache P, et al. Change in fracture risk and fracture pattern after bariatric surgery: nested case-control study. BMJ. 2016;354:i3794.CrossRefGoogle Scholar
  34. 34.
    Yu EW, Lee MP, Landon JE, Lindeman KG, Kim SC. Fracture risk after bariatric surgery: Roux-en-Y gastric bypass versus adjustable gastric banding. J Bone Miner Res. 2.Google Scholar
  35. 35.
    Axelsson KF, Werling M, Eliasson B, et al. Fracture risk after gastric bypass surgery: a retrospective cohort study. J Bone Miner Res. 2018;33(12):2122–31.CrossRefGoogle Scholar
  36. 36.
    Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab. 1988;67(2):373–8.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Endocrinology and Internal MedicineAarhus University HospitalAarhus NDenmark
  2. 2.Department of Clinical MedicineAarhus UniversityAarhus NDenmark
  3. 3.Department of Clinical BiochemistryRigshospitaletCopenhagenDenmark
  4. 4.Odense Patient Data Explorative NetworkOdense University Hospital/Institute of Clinical ResearchOdense CDenmark

Personalised recommendations